VAXIN LAUNCHES JOINT VENTURE WITH ANC BIO IN KOREA
Impax Laboratories Settles Pending Litigation for FLOMAX(R)
Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc
Biovail Provides Update on Pimavanserin Collaborative Development Program
KIMBERLY-CLARK ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE I-FLOW CORPORATION